Columbus Macro LLC Purchases 10,350 Shares of iShares Biotechnology ETF $IBB

Columbus Macro LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 10,350 shares of the financial services provider’s stock, valued at approximately $2,179,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MinichMacGregor Wealth Management LLC boosted its position in shares of iShares Biotechnology ETF by 3,323.4% in the third quarter. MinichMacGregor Wealth Management LLC now owns 78,396 shares of the financial services provider’s stock valued at $16,505,000 after acquiring an additional 76,106 shares during the period. Focus Financial Network Inc. increased its position in iShares Biotechnology ETF by 6.3% during the third quarter. Focus Financial Network Inc. now owns 6,056 shares of the financial services provider’s stock worth $1,275,000 after acquiring an additional 359 shares during the period. B. Riley Wealth Advisors Inc. increased its position in iShares Biotechnology ETF by 87.4% during the third quarter. B. Riley Wealth Advisors Inc. now owns 2,897 shares of the financial services provider’s stock worth $610,000 after acquiring an additional 1,351 shares during the period. Ulrich Consultants & Investment Group LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $423,000. Finally, GK Wealth Management LLC bought a new position in iShares Biotechnology ETF during the third quarter worth about $94,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock traded up $3.23 during midday trading on Wednesday, hitting $203.25. The company’s stock had a trading volume of 1,128,899 shares, compared to its average volume of 1,646,237. iShares Biotechnology ETF has a 1-year low of $151.01 and a 1-year high of $217.12. The company has a 50-day moving average price of $206.36 and a two-hundred day moving average price of $187.17.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a $0.0112 dividend. The ex-dividend date was Tuesday, September 15th. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.0%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.